Generation Of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus Use Of SPYMEG As A Novel Human Lymphocyte Fusion Partner
Medical & Biological Laboratories Co., Ltd. (MBL), with the collaboration of Osaka University, has successfully generated several fully human monoclonal antibodies against pandemic A (H1N1 and H3N2) type influenza virus by utilizing blood samples from volunteers who were inoculated with influenza vaccine. Professor Kazuyoshi Ikuta, Ph. D... (Source: Immune System / Vaccines News From Medical News Today)




